Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Developing treatments for indolent non hodgkin lymphoma

Dr Andrew Davies and Dr Paul Fields

Developing treatments for indolent non hodgkin lymphoma ( Dr Andrew Davies and Dr Paul Fields )

The evolution of CLL treatment

Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence...

The evolution of CLL treatment ( Prof Clemens Wendtner, Dr Francesc Bosch, Prof Paolo Ghia and Prof Florence Cymbalista )

New T cell–based immunotherapy shows promise for lethal stem cell transplant...

Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA )

DNA repair inhibitors to overcome drug resistance

Dr Ruth Plummer - Newcastle University, Newcastle, UK

DNA repair inhibitors to overcome drug resistance ( Dr Ruth Plummer - Newcastle University, Newcastle, UK )

Putting adoptive T cell therapy on the path to regulatory approval

Prof Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA

Putting adoptive T cell therapy on the path to regulatory approval ( Prof Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )

New drugs and targets in haematological malignancies

Dr Renier Brentjens - Memorial Sloan Kettering Cancer Center, New York, USA

New drugs and targets in haematological malignancies ( Dr Renier Brentjens - Memorial Sloan Kettering Cancer Center, New York, USA )

ecancermedicalscience editor's choice for February 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience editor's choice for February 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

ASCO GU 2015 news roundup

Peter Goodwin - ecancer correspondent, London, UK

ASCO GU 2015 news roundup ( Peter Goodwin - ecancer correspondent, London, UK )

Efficacy, tolerability and quality of life in metastatic renal cell carcinoma:...

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France

Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )

mRCC: Are we doing all we can to manage adverse events?

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France

mRCC: Are we doing all we can to manage adverse events? ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )

mRCC: Real-world experience: achieving efficacy beyond clinical trials

Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA

mRCC: Real-world experience: achieving efficacy beyond clinical trials ( Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA )

mRCC: Understanding the patient's perspective

Dr David Cella - Northwestern University, Chicago, USA

mRCC: Understanding the patient's perspective ( Dr David Cella - Northwestern University, Chicago, USA )

More from ecancer